← FDA Drug Approvals (Drugs@FDA)

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LIMITED · Approved 2025-10-10

Drug application

FDA Application #

ANDA211680

Application type

Abbreviated New Drug Application (Generic)

Brand name

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Generic name

Emtricitabine, Tenofovir Alafenamide

Active ingredients

EMTRICITABINE, TENOFOVIR ALAFENAMIDE

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LIMITED

First approval

2025-10-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown